Risk factors for healthcare-associated infections caused by cefepime-resistant Pseudomonas aeruginosa
Introduction: The increasing resistance of Pseudomonas aeruginosa against cefepime requires a better understanding of hospital epidemiology in order to retain this drug as a therapeutic option. Aim: The aim of this study was to identify risk factors associated with healthcare associated infections (...
Main Authors: | Folić Marko M., Đorđević Zorana M., Milovanović Dragan R., Ružić-Zečević Dejana T., Rosić Nikola V., Janković Slobodan M. |
---|---|
Format: | Article |
Language: | English |
Published: |
Srpsko lekarsko drustvo
2020-01-01
|
Series: | Hospital Pharmacology |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2020/2334-94922002923F.pdf |
Similar Items
-
Cefepime-Resistant Pseudomonas aeruginosa
by: Ehimare Akhabue, et al.
Published: (2011-06-01) -
Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study
by: Ting-Yi Su, et al.
Published: (2017-07-01) -
Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of Acinetobacter spp. and Pseudomonas aeruginosa Isolated from Patients with Nosocomial Infections
by: Zorana M. Djordjevic, et al.
Published: (2017-12-01) -
Lessons Learned from Surveillance of Antimicrobial Susceptibilities of Pseudomonas aeruginosa at a Large Academic Medical Center
by: Brett H. Heintz, et al.
Published: (2010-04-01) -
Preparation, characterization and in vitro antimicrobial activity of liposomal ceftazidime and cefepime against Pseudomonas aeruginosa strains
by: Ieda Maria Sapateiro Torres, et al.
Published: (2012-09-01)